Skip to main content

2024 ISPE Annual Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Mark Lunt

Versus Arthritis Epidemiology Unit, The University of Manchester, Manchester, United Kingdom, United Kingdom

Poster(s):

(009) Drug survival and safety of biosimilars compared with originator adalimumab for Psoriasis: a multinational cohort study

Monday, August 26, 2024
8:00 AM – 6:00 PM CEST
(036) Serious Infection Risk Associated With Biologics and Systemic Nonbiologics in Patients With Psoriasis: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials

Monday, August 26, 2024
8:00 AM – 6:00 PM CEST